Puntuación ASPECTS basal predice deterioro neurológico temprano y resultados funcionales después de trombectomía...

Early neurological deterioration (END), defined as neurological decline after endovascular thrombectomy (EVT) for acute ischemic stroke (AIS), is a critical complication associated with poor long-term prognosis. Although END significantly impacts clinical outcomes, its underlying mechanisms and modifiable risk factors remain poorly understood. This study aimed to (1) characterize the clinical profile of END and (2) evaluate its association with 90-day functional outcomes in AIS patients who underwent EVT.

This retrospective study included consecutive patients with acute ischemic stroke (AIS) secondary to large vessel occlusion (LVO) who were treated with endovascular thrombectomy (EVT) between January 2021 and December 2024. END was defined as either a ≥4-point increase in the National Institutes of Health Stroke Scale (NIHSS) score or a ≥1-point increase in the NIHSS consciousness subscore (Item Ia) within 72 h after EVT. Patients meeting these criteria were classified into the END group; others comprised the non-END group. Variables with a p-value of <0.05 in univariate analysis were included in a multivariable logistic regression model to identify independent predictors of END. The predictive performance of the Alberta Stroke Program Early CT Score (ASPECTS) was assessed through receiver operating characteristic (ROC) analysis, with the optimal cutoff determined by maximizing the Youden index.

The study included 177 consecutive AIS patients with LVO who were treated with EVT. END occurred in 52 patients (29.4%). The END group had significantly lower baseline ASPECTS values than the non-END group (median [IQR]: 7 [6-8] vs. 9 [8-9], p < 0.001). In the adjusted analysis, higher ASPECTS was independently associated with a reduced risk of END (OR = 0.59 per 1-point increase, 95% CI: 0.44-0.80, p = 0.001). ROC analysis identified an ASPECTS ≤7 as the optimal cutoff for predicting END (AUC = 0.761; sensitivity 75.0%, specificity 76.8%). At 90 days, functional independence [modified Rankin Scale (mRS) 0-2] was achieved in 52.0% of the non-END group versus 7.6% of the END group (p < 0.001).

END after EVT independently predicts poor 90-day functional independence (mRS 0-2) in LVO-related AIS. Our findings support incorporating a baseline ASPECTS ≤7 into risk stratification protocols to identify high-risk patients requiring intensive neuromonitoring (hourly NIHSS assessments for 72 h post-EVT). Early detection of END signs, such as a ≥ 4-point increase in the NIHSS score 4, may enable prompt interventions (e.g., blood pressure control or edema management) to improve long-term outcomes.